Andrea Frohning (SVP, CHRO) reports withholding 788 XRAY shares for taxes

Rhea-AI Filing Summary

Andrea L. Frohning, Senior Vice President and CHRO of DENTSPLY SIRONA Inc. (ticker XRAY), reported a transaction on 08/08/2025 on Form 4. The filing shows 788 shares of common stock were withheld to cover taxes related to the vesting of restricted stock units and dividend equivalent units previously reported. The transaction is reported with code F and a price of $12.96 per share.

After the withholding, the beneficial ownership reported for Ms. Frohning is 33,252.812 shares, held directly. The Form identifies the reporting person and the issuer but does not disclose any open-market purchases or sales separate from the tax-withholding event.

Insights

Securities Analyst

TL;DR: Officer withheld 788 shares to satisfy tax obligations on vested RSUs; reported holdings remain at 33,252.812 shares.

The Form 4 discloses a non-sale disposition labeled with transaction code F on 08/08/2025, reflecting withholding of 788 shares at $12.96 to cover taxes tied to vested restricted stock units and dividend equivalents. This transaction is a compensation-related settlement rather than a market trade, and the filing reports 33,252.812 shares beneficially owned directly following the action. For investors, this is a disclosure of an executive’s compensation settlement with no indication of a purposeful liquidity event.

Corporate Governance Expert

TL;DR: Form 4 shows a compensation-related withholding; disclosure and signature by attorney-in-fact indicate standard internal handling.

The report names Andrea L. Frohning as the reporting person and lists her relationship to the issuer as an officer (SVP, CHRO). The explanatory note explicitly states the withheld shares were to cover taxes on vested equity and dividend equivalents, which aligns with common equity compensation administration. The presence of an attorney-in-fact signature documents authorized filing steps. There is no indication in the form of governance concerns or regulatory issues.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Frohning Andrea L.

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CHRO

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/08/2025		F		788(1)	D	$12.96	33,252.812	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

	/s/ Jessica Causey, Attorney-IN-Fact for Andrea Frohning	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Andrea L. Frohning report on the Form 4 for XRAY?

She reported withholding 788 shares to cover taxes on vested restricted stock units and dividend equivalents, with a reported price of $12.96 per share.

When was the reported transaction for XRAY executed?

The transaction date reported is 08/08/2025.

How many shares does Andrea Frohning beneficially own after the transaction?

The Form reports 33,252.812 shares beneficially owned directly following the reported transaction.

What is the relationship of the reporting person to DENTSPLY SIRONA (XRAY)?

Andrea L. Frohning is listed as an Officer with the title SVP, CHRO.

Why were shares withheld according to the filing?

The filing explanation states the shares were withheld to cover taxes related to the vesting of restricted stock units and dividend equivalent units.

Who signed the Form 4 for Andrea Frohning?

The signature block shows Jessica Causey, Attorney-in-Fact signed on behalf of Andrea Frohning.